ENDRA Life Sciences (NDRA) Other Operating Expenses (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Other Operating Expenses for 11 consecutive years, with $776410.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses rose 46.86% year-over-year to $776410.0; the TTM figure through Mar 2026 stood at $50367.0 (down 96.43% YoY), while the FY2025 annual figure was $189470.0, down 94.06% from the prior year.
• Other Operating Expenses grew to $776410.0 in Q1 2026 per NDRA's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $1.6 million in Q3 2023 and bottomed at -$3.6 million in Q4 2023.
• Historically, Other Operating Expenses has averaged -$129360.2 across 5 years, with a median of $247773.0 in 2023.
• Annual changes were most pronounced in 2023 — Other Operating Expenses surged 288.37% — and 2025, when it slumped 280.64%.
• ENDRA Life Sciences' Other Operating Expenses stood at -$3.5 million in 2022, then slipped by 4.1% to -$3.6 million in 2023, then soared by 117.7% to $637957.0 in 2024, then plunged by 280.64% to -$1.2 million in 2025, then jumped by 167.37% to $776410.0 in 2026.
• Business Quant data shows NDRA's Other Operating Expenses at $776410.0 in Q1 2026, -$1.2 million in Q4 2025, and $45285.0 in Q3 2025.